Skip to main content
. 2022 May 11;17(1):31. doi: 10.5334/gh.1120

Table 1.

Baseline characteristics and prevalence of hypertension in the population of the Tehran Cohort Study.


TOTAL POPULATION*
n = 8296
NORMAL/OPTIMAL
n = 3962 (48.0)
HIGH NORMAL
n = 1007 (12.2)
HYPERTENSION
n = 3288 (39.8)
P-VALUE

Age, year, mean (SD) 53.8 (12.75) 48.60 (10.9) 53.4 (11.77) 60.2 (12.16) <0.001

Age, year, n (%) <0.001

    35–44 2329 (28.1) 1693 (73.1) 262 (11.3) 360 (15.6)

    45–54 2209 (26.6) 1190 (54.1) 312 (14.2) 696 (31.7)

    55–64 1967 (23.7) 722 (36.8) 233 (11.9) 1008 (51.3)

    65–74 1222 (14.7) 265 (21.8) 152 (12.5) 800 (65.7)

    ≥75 569 (6.9) 92 (16.3) 48 (8.5) 424 (75.2)

Sex, n (%) 0.013

    Men 3818 (46.0) 1794 (47.2) 507 (13.3) 1500 (39.5)

    Women 4478 (54.0) 2168 (48.7) 500 (11.2) 1788 (40.1)

Marital status, n (%) 0.663

    Married 8210 (99.2) 3929 (48.0) 1001 (12.2) 3258 (39.8)

    Non-married 86 (0.8) 31 (47.0) 6 (9.1) 29 (43.9)

Ethnicity, n (%) 0.224

    Fars 4026 (48.8) 1877 (46.6) 510 (12.7) 1639 (40.7)

    Azari 2447 (29.7) 1187 (48.5) 290 (11.9) 970 (39.6)

    Gilak 330 (4.0) 166 (50.3) 34 (10.3) 130 (39.4)

    Lor 318 (3.9) 175 (55.0) 28 (8.8) 115 (36.2)

    Kurd 193 (2.3) 98 (50.8) 26 (13.5) 69 (35.8)

    Mixed 680 (8.2) 331 (48.7) 79 (11.6) 270 (39.7)

    Other 206 (2.5) 102 (49.5) 32 (15.5) 72 (35.0)

    Immigrants/Refugees 51 (0.6) 23 (45.1) 8 (15.7) 20 (39.2)

Education, year, n (%) <0.001

    Illiterate 585 (7.1) 141 (24.1) 51 (8.7) 393 (67.2)

    (1–5) 841 (10.2) 286 (34.1) 98 (11.7) 455 (54.2)

    (6–12) 4306 (52.0) 2070 (48.2) 559 (13.0) 1662 (38.7)

    >12 2541 (30.7) 1461 (57.6) 299 (11.8) 776 (30.6)

Body mass index, kg/m2, n (%) <0.001

    <20 227 (2.8) 158 (69.6) 25 (11.0) 44 (19.4)

    20–24.9 2079 (25.3) 1251 (60.5) 243 (11.7) 575 (27.8)

    25–29.9 3426 (41.7) 1661 (48.6) 438 (12.8) 1320 (38.6)

    30–34.9 1796 (21.9) 680 (37.9) 221 (12.3) 892 (49.7)

    ≥35 683 (8.3) 193 (28.3) 76 (11.1) 413 (60.6)

Diabetes, n (%) <0.001

    No 6965 (84.4) 3640 (52.2) 895 (12.8) 2430 (34.9)

    Yes 1292 (15.6) 322 (24.9) 112 (8.7) 858 (66.4)

Hyperlipidemia, n (%) <0.001

    No 5562 (67.4) 3122 (56.1) 759 (13.6) 1681 (30.2)

    Yes 2694 (32.6) 839 (31.1) 248 (9.2) 1607 (59.7)

Chronic kidney disease, n (%) <0.001

    No 8187 (99.1) 3948 (48.2) 1005 (12.3) 3234 (39.5)

    Yes 71 (0.9) 14 (19.7) 2 (2.8) 55 (77.5)

Serum Creatinine, mg/dL, median (25th, 75th percentile) 0.80 (0.70, 0.94) 0.79 (0.69, 0.90) 0.80 (0.70, 0.93) 0.84 (0.71, 1.00) <0.001

Tobacco user, n (%) <0.001

    Current 1594 (19.3) 911 (57.2) 185 (11.6) 498 (31.2)

    Former 333 (4.0) 110 (33.0) 40 (12.0) 183 (55.0)

    Never 6325 (76.6) 2937 (46.4) 782 (12.4) 2606 (41.2)

Opium consumption, n (%) 0.309

    No 7856 (94.7) 3750 (48.1) 948 (12.2) 3091 (39.7)

    Yes 440 (5.3) 194 (44.4) 58 (13.3) 185 (42.3)

Alcohol consumption, n (%) 0.001

    No 7555 (91.0) 3540 (47.3) 919 (12.3) 3024 (40.4)

    Yes 741 (9.0) 402 (54.6) 84 (11.4) 250 (34.0)

Physical activity, n (%) <0.001

    Low 1449 (17.6) 539 (37.3) 127 (8.8) 779 (53.9)

    Intermediate 4764 (58.0) 2311 (48.6) 592 (12.5) 1845 (38.9)

    High 2000 (24.4) 1082 (54.2) 282 (14.1) 632 (31.7)

* Categorical data are reported as number (percentage in the column).

Categorical data are reported as number (percentage in a row).

P-value is calculated between normal/optimal, high normal, and hypertension subgroups.